NASDAQ: SIENSientra Inc Stock
$0.84-0.03 (-3.45%)
Updated Nov 29, 2023
SIEN Price
$0.84
Fair Value Price
N/A
Market Cap
$10.03M
52 Week Low
$0.59
52 Week High
$4.94
P/E
-0.16x
P/B
-0.31x
P/S
0.35x
PEG
N/A
Dividend Yield
N/A
Revenue
$90.30M
Earnings
-$59.12M
Gross Margin
42.1%
Operating Margin
-54.62%
Profit Margin
-65.5%
Debt to Equity
-5.37
Operating Cash Flow
-$11M
Beta
1.65
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
SIEN Overview
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SIEN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SIEN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SIEN is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
SIEN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more SIEN due diligence checks available for Premium users.
Be the first to know about important SIEN news, forecast changes, insider trades & much more!
SIEN News
Valuation
SIEN fair value
Fair Value of SIEN stock based on Discounted Cash Flow (DCF)
Price
$0.84
Fair Value
$3.96
Undervalued by
78.79%
SIEN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SIEN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.16x
Industry
35.04x
Market
29.48x
SIEN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.31x
Industry
3.53x
SIEN's financial health
Profit margin
Revenue
$19.5M
Net Income
-$14.8M
Profit Margin
-75.6%
SIEN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SIEN's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$139.9M
Liabilities
$172.0M
Debt to equity
-5.37
SIEN's short-term liabilities ($152.09M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SIEN's short-term assets ($86.51M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SIEN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SIEN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.4M
Investing
-$270.0k
Financing
$25.0k
SIEN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SIEN vs Medical Device Stocks
Sientra Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.